Min Wang


Min joined Monte Rosa from BlueRock Therapeutics, where she was COO and played a key role in shaping its strategy and operations, including the sale of the company for an implied total value of up to $1 billion. She previously served as Senior Vice President, General Counsel at Agios from inception through its IPO to a fully integrated biopharma...

Roles at Monte Rosa Therapeutics

  • COO

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Monte Rosa Therapeutics

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.